News | March 15, 2022

PASSAGE BIO PROVIDES UPDATE ON STRATEGIC PRIORITIES AND EXTENDS CASH RUNWAY Company to reduce workforce and prioritize research and development programs to reduce operating expenses Continued focus on execution of three ongoing clinical trials for GM1 gangliosidosis,...

News | April 21, 2022

Kyruus and Upfront Partner to Enable Healthcare Organizations to Maximize Digital Patient Acquisition and Retention Partnership Offers Consumer-Centric Search and Scheduling Options While Closing Gaps in Care through Personalized Digital Outreach to Patients Boston,...

News | March 10, 2022

WellHive Announces Partnership with Kyruus to Integrate Systems and Optimize Care Navigation for Veterans Melbourne, FL – WellHive, the leader in digital care navigation within the federal government, today announced a novel partnership with Kyruus, the industry...

News | March 9, 2022

UPMC and Kyruus Launch Strategic Partnership to Transform Digital Patient Access and Care Navigation World-Renowned Healthcare Provider and Insurer Deepens Relationship through Direct Investment and Collaboration with Leading Digital Health Company Boston, MA – March...

News | April 12, 2022

Deciphera Pharmaceuticals Presents Preclinical Data from DCC-3116 Program at the AACR Annual Meeting – ULK Inhibitor DCC-3116 Shown to Inhibit KRASG12C Inhibitor-induced Autophagy in Mutant KRASG12C NSCLC Cell Lines – – DCC-3116 in Combination with KRASG12C Inhibitors...

News | April 7, 2022

Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates Proposed acquisition strengthens Pfizer’s capabilities in infectious disease research and development with a complementary strategy to help improve patient outcomes through treatment...